MINNEAPOLIS, June 9, 2020 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ:TECH) is at the forefront of coronavirus disease 2019 (COVID-19) and SARS-CoV-2 research. This is evidenced by the large number ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

Narrow-moat Bio-Techne reported strong fiscal first-quarter earnings, with year-over-year organic revenue up 10% and EPS of $0.83, up from $0.37 last year. While revenue is tracking slightly ahead of ...